[go: up one dir, main page]

NO20043840L - Mikrogliahemmere til stopping av immunreaksjoner som er indusert av indusert av interleukin-12 og IFN-gamma - Google Patents

Mikrogliahemmere til stopping av immunreaksjoner som er indusert av indusert av interleukin-12 og IFN-gamma

Info

Publication number
NO20043840L
NO20043840L NO20043840A NO20043840A NO20043840L NO 20043840 L NO20043840 L NO 20043840L NO 20043840 A NO20043840 A NO 20043840A NO 20043840 A NO20043840 A NO 20043840A NO 20043840 L NO20043840 L NO 20043840L
Authority
NO
Norway
Prior art keywords
ifn
interleukin
gamma
stopping
immune reactions
Prior art date
Application number
NO20043840A
Other languages
English (en)
Inventor
Herbert Schneider
Wolfgang Halfbrodt
Thorsten Blume
Joachim Kuhnke
Ursula Monning
Wolf-Dietrich Doche
Bernd Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20043840L publication Critical patent/NO20043840L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20043840A 2002-02-15 2004-09-14 Mikrogliahemmere til stopping av immunreaksjoner som er indusert av indusert av interleukin-12 og IFN-gamma NO20043840L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10207843A DE10207843A1 (de) 2002-02-15 2002-02-15 Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
PCT/EP2003/000467 WO2003068225A1 (de) 2002-02-15 2003-01-17 Mikroglia-inhibitoren zur unterbrechung von interleukin 12 und ifn-gamma vermittelten immunreaktionen

Publications (1)

Publication Number Publication Date
NO20043840L true NO20043840L (no) 2004-11-12

Family

ID=27674912

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043840A NO20043840L (no) 2002-02-15 2004-09-14 Mikrogliahemmere til stopping av immunreaksjoner som er indusert av indusert av interleukin-12 og IFN-gamma

Country Status (21)

Country Link
EP (1) EP1474138A1 (no)
JP (1) JP2005522447A (no)
KR (1) KR20040084909A (no)
CN (1) CN1756546A (no)
AR (1) AR039556A1 (no)
AU (1) AU2003245523A1 (no)
BR (1) BR0307706A (no)
CA (1) CA2475770A1 (no)
DE (1) DE10207843A1 (no)
EC (1) ECSP045297A (no)
MX (1) MXPA04007943A (no)
NO (1) NO20043840L (no)
PE (1) PE20030906A1 (no)
PL (1) PL371327A1 (no)
RS (1) RS71304A (no)
RU (1) RU2004127677A (no)
TW (1) TW200306823A (no)
UA (1) UA81111C2 (no)
UY (1) UY27662A1 (no)
WO (1) WO2003068225A1 (no)
ZA (1) ZA200407382B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207844A1 (de) * 2002-02-15 2003-09-04 Schering Ag 1-Phenyl-2-heteroaryl-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
CA2601557A1 (en) * 2005-03-17 2006-09-21 Proyteco De Biomedicina Cima, S.L. Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection
TR201807207T4 (tr) * 2012-06-11 2018-06-21 Ucb Biopharma Sprl Tnf-alfa modüle edici benzimidazol bileşikleri.
WO2016130501A1 (en) 2015-02-09 2016-08-18 Incyte Corporation Aza-heteroaryl compounds as pi3k-gamma inhibitors
US10065963B2 (en) 2015-11-06 2018-09-04 Incyte Corporation Heterocyclic compounds as PI3K-γ inhibitors
KR20180094989A (ko) * 2015-12-15 2018-08-24 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 노화 관련 인지장애 및 신경염증의 예방 및/또는 치료 방법
ES2995198T3 (en) 2016-01-05 2025-02-07 Incyte Corp Pyridine compounds as pi3k-gamma inhibitors
AR108875A1 (es) 2016-06-24 2018-10-03 Incyte Corp COMPUESTOS HETEROCÍCLICOS COMO INHIBIDORES DE PI3K-g
MD3697789T2 (ro) 2017-10-18 2022-02-28 Incyte Corp Derivați imidazol condensați substituiți cu grupări hidroxi terțiare ca inhibitori PI3K-GAMA
CR20250050A (es) 2018-09-05 2025-03-19 Incyte Corp Formas cristalinas de un inhibidor de fosfoinositida 3–quinasa (pi3k) (divisional 2021-0165)
LT3860998T (lt) 2018-10-05 2024-06-25 Annapurna Bio Inc. Junginiai ir kompozicijos, skirti gydyti būkles, susijusias su apj receptoriaus aktyvumu
CN112341451B (zh) * 2019-08-09 2022-06-17 成都先导药物开发股份有限公司 一种免疫调节剂
CN112341450B (zh) * 2019-08-09 2022-05-17 成都先导药物开发股份有限公司 一种免疫调节剂
US20230056497A1 (en) * 2019-12-19 2023-02-23 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services CD206 Modulators Their Use and Methods for Preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
HU228366B1 (en) * 2000-01-14 2013-03-28 Schering Ag 1,2-diaryl benzimidazoles, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions for treating illnesses associated with a microglia activation
DE10134775A1 (de) * 2001-07-06 2003-01-30 Schering Ag 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
DE10135050A1 (de) * 2001-07-09 2003-02-06 Schering Ag 1-Ary1-2-N-, S- oder O-substituierte Benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
EP1474138A1 (de) 2004-11-10
UA81111C2 (en) 2007-12-10
RU2004127677A (ru) 2005-06-10
CN1756546A (zh) 2006-04-05
ZA200407382B (en) 2005-09-14
BR0307706A (pt) 2005-01-11
KR20040084909A (ko) 2004-10-06
PL371327A1 (en) 2005-06-13
RS71304A (sr) 2006-10-27
WO2003068225A1 (de) 2003-08-21
DE10207843A1 (de) 2003-09-04
CA2475770A1 (en) 2003-08-21
PE20030906A1 (es) 2004-01-17
TW200306823A (en) 2003-12-01
AR039556A1 (es) 2005-02-23
ECSP045297A (es) 2004-10-26
AU2003245523A1 (en) 2003-09-04
UY27662A1 (es) 2003-09-30
MXPA04007943A (es) 2004-11-26
JP2005522447A (ja) 2005-07-28

Similar Documents

Publication Publication Date Title
NO20044915L (no) C-aryl-glukosid SGLT2 inhibitorer og metode
DK1415535T3 (da) Spröjtesystem og fremgangsmåde til et sådant
DK1539115T3 (da) Fremgangsmåder og doseringsformer til kontrolleret levering af paliperidon
DK1675279T3 (da) Fremgangsmåde og indretning til synkronisering af basisstationer
DK1997809T3 (da) P38-inhibitorer og fremgangsmåder til anvendelse deraf
IS2675B (is) P38-hindrar og aðferðir til notkunar þeirra
NO20043840L (no) Mikrogliahemmere til stopping av immunreaksjoner som er indusert av indusert av interleukin-12 og IFN-gamma
NO20052462D0 (no) Kombinasjonsterapi under anvendelse av 1-aminosykloheksanderivater og acetyl-cholinesteraseinhibitorer
IS7645A (is) Stillar glúkósteraviðtaka og aðferð
DK2267930T3 (da) Fremgangsmåde og indretning til retransmission
NO20052139L (no) Bandasje og epidermal posisjoneringsmekanisme og fremgangsmate for anvendelse av samme
IS7090A (is) Kerfi,aðferð og tölvuhugbúnaður til að forma og kaupa lækningatæki
DK1532569T3 (da) Fremgangsmåde og indretning til kodning af genstande
DK1426784T3 (da) Indretning og fremgangsmåde til positionsbestemmelse
IS7655A (is) Aðferð og kerfi fyrir sjálfvirka staðfestingu leyfishafa
ITMI20032401A1 (it) Procedimento e dispositivo per il funzionamento di un
DK1344451T3 (da) Indretning og opstilling til en dyrerelateret handling
NO20043002L (no) Anordning og fremgangsmate til diskontinuerlig polykondensasjon
ITRM20030236A1 (it) Procedimento ed apparecchio per la simulazione
FI20020162L (fi) Menetelmä ja laite kuumaliimaukseen
DK1565574T3 (da) Produkt og fremgangsmåde
DK1426293T3 (da) Fremgangsmåde og indretning til emballering af flade genstande
IS7541A (is) Aðferð og hleðslueining til að dreifa vörum
DK1426294T3 (da) Fremgangsmåde og indretning til emballering af flade genstande
ITMI20030178A1 (it) Apparecchiatura e procedimento di fissaggio/ritenuta

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application